tradingkey.logo
tradingkey.logo
Search

Fulgent Genetics Inc

FLGT
Add to Watchlist
23.740USD
+5.080+27.22%
Close 11-06 16:00(ET)
653.32MMarket Cap
LossP/E TTM

Today

+27.22%

5 Days

+15.13%

1 Month

+14.02%

6 Months

+48.75%

Year to Date

-9.63%

1 Year

-9.94%

Key Figures

20.470Open
23.850High
65.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.24%Turnover Ratio
18.660Prev. Close
19.640Low
1.48MTurnover
LossP/E Static
0.65P/B
0.00%Div Yield TTM
-6.35%ROA
31.04052wk High
0.21Volume Ratio
-42.71MNet Profit
27.52MShares
-2.3961EPS TTM
0.93Beta
-6.78%ROE
13.46052wk Low
28.27%Amplitude
27.17%Gross Margin
653.32MMarket Cap
-2.08Reward/Risk
4.08%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

Fulgent Genetics Inc's Score

0.28vs previous score
Forecast6.00
Financial Health6.66
Technical4.97
Valuation Dimensions9.00
Institutional Confidence5.00
Risk Assessment5.58

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
19.000Target Price
-7.86%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy00000000
Buy00000122
Hold11111111
Sell00000000
Strong Sell00000000

Fulgent Genetics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Fulgent Genetics Inc Latest Earnings Call Transcripts

Fulgent Genetics (FLGT) Q3 2026 Earnings Call: Revenue Rises 8%, Loss Narrows

Fulgent Genetics Q3 2026 revenue rose 8% to $90.4 million as losses narrowed, billing collections improved, and full-year guidance was reaffirmed.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
--/-0.65
Revenue / Forecast
--/86.30M

Fulgent Genetics Inc Profile

SectorHealthcare Providers & Services
Ticker SymbolFLGT
Number of employees1313
CountryUnited States of America

Ownership

ShareholdersProportion
Hsieh (Ming)31.22%
BlackRock Institutional Trust Company, N.A.7.09%
Acadian Asset Management LLC4.18%
Millennium Management LLC3.31%
Shareholder TypesProportion
Individual Investor36.64%
Investment Advisor/Hedge Fund24.14%
Investment Advisor22.96%
Hedge Fund12.61%

FAQs

What is the current price of Fulgent Genetics Inc (FLGT)?

The current price of Fulgent Genetics Inc (FLGT) is 23.74.

What is the symbol of Fulgent Genetics Inc?

The ticker symbol of Fulgent Genetics Inc is FLGT.

What is the 52-week high of Fulgent Genetics Inc?

The 52-week high of Fulgent Genetics Inc is 31.04.

What is the 52-week low of Fulgent Genetics Inc?

The 52-week low of Fulgent Genetics Inc is 13.46.

What is the market capitalization of Fulgent Genetics Inc?

The market capitalization of Fulgent Genetics Inc is 653.32M.

Is Fulgent Genetics Inc (FLGT) currently rated as Buy, Hold, or Sell?

According to analysts, Fulgent Genetics Inc (FLGT) has an overall rating of signal_hold, with a price target of 19.00.

What is the Earnings Per Share (EPS TTM) of Fulgent Genetics Inc (FLGT)?

The Earnings Per Share (EPS TTM) of Fulgent Genetics Inc (FLGT) is -2.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.